Investing in Life Sciences
May 11, 2026
11 min
Full
5,286 of 5,353
May 11, 2026
Investing in Life Sciences
0:00 / 11:34
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Bloomberg Originals Episodes Around May 11, 2026
Episode 5,286 of 5,353 — walk the feed in the order it was published.
11:34This episodeInvesting in Life Sciences
Summary
<p>Blackstone Life Sciences, which has some $17 billion in assets under management, typically invests in late-stage medicines invented by biotech and pharmaceutical companies in exchange for a royalty on future sales. In 2024, for example, the firm invested as much as $750 million in financing for Moderna’s flu vaccine development.<br /><br />But Blackstone also wants to own a stake in some companies that it backs. <br />In late March, Blackstone closed its latest life-sciences fund with $6.3 billion of commitments, the firm’s biggest haul for backing clinical trials of medicines and technologies. <br /><br />Dr. Jenny Rooke is Founder and Managing Director of Genoa Ventures. She discusses the cross between tech and health with Carol Massar and Tim Stenovec.</p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.